Virksomhedsstatus | NORMAL. |
Sidst opdateret den 09.02.2015 og
angivet som gældende fra 03.12.2012 (4284
dage). |
Ingen historik.
Branche | Forskning og eksperimentel udvikling indenfor bioteknologi (721100). |
Sidst opdateret den 02.01.2013 og
angivet som gældende fra 03.12.2012 (4284
dage). |
Ingen historik.
Revisionfravalgt | false. |
Sidst opdateret den 11.03.2015 og
angivet som gældende fra 03.12.2012 (4284
dage). |
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Navne | GALECTO BIOTECH ApS. |
Sidst opdateret den 05.12.2012 og
angivet som gældende fra 03.12.2012 (4284
dage). |
Ingen historik.
Tegningsregel | Selskabet tegnes af to bestyrelsesmedlemmer i forening, af et bestyrelsesmedlem og en direktør i forening eller af den samlede bestyrelse. |
Sidst opdateret den 26.10.2020 og
angivet som gældende fra 26.10.2020 (1400
dage). |
Fortolkning
(3 tegningsmuligheder)
| 2 bestyrelsesmedlemmer + |
1 bestyrelsesmedlem + 1 direktør |
bestyrelsen |
Historik | Start | Stop |
---|
Selskabet tegnes af to bestyrelsesmedlemmer i forening, af et bestyrelsesmedlem og en direktør i forening eller af den samlede bestyrelse | 26.10.2020 | |
Selskabet tegnes af en direktør | 03.12.2012 | 25.10.2020 |
Type af revisorbistand:Revisionspåtegning
Navn på revisionsvirksomhed:EY
Revisionsvirksomhedens CVR-nr.:30700228
Beskrivelse af revisor:statsautoriseret revisor
Virksomhedens regnskabsklasse:Regnskabsklasse B
Grundlag for konklusion (revision):We conducted our audit in accordance with International Standards on Auditing (ISAs) and additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the "Auditor's responsibilities for the audit of the financial statements" section of our report. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Independence
We are independent of the Company in accordance with the International Ethics Standards Board for Accountants' International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code.
Konklusion (revision):We have audited the financial statements of Galecto Biotech ApS for the financial year 1 January – 31 December 2023, which comprise income statement, balance sheet, statement of changes in equity and notes, including accounting policies. The financial statements are prepared in accordance with the Danish Financial Statements Act.
In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2023 and of the results of the Company's operations for the financial year 1 January – 31 December 2023 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Statement on management's review
Management is responsible for management's review.
Our opinion on the financial statements døs not cover management's review, and we do not express any form of assurance conclusion thereon.
In connection with our audit of the financial statements, our responsibility is to read management's review and, in doing so, consider whether management's review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated.
Moreover, it is our responsibility to consider whether management's review provides the information required under the Danish Financial Statements Act.
Based on the work we have performed, we conclude that management's review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statements Act. We did not identify any material misstatement of management's review.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.